Header
Header
Article

New patent expiration for COVIS drug TUDORZA PRESSAIR – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for COVIS drug TUDORZA PRESSAIR


Annual Drug Patent Expirations for TUDORZA+PRESSAIR

Tudorza Pressair is a drug marketed by Covis and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has one hundred and twenty-nine patent family members in forty-five countries.

The generic ingredient in TUDORZA PRESSAIR is aclidinium bromide. One supplier is listed for this compound. Additional details are available on the aclidinium bromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for COVIS drug TUDORZA PRESSAIR



Source link

Back to top button